Safe antileukemia drug, SAL

Details Safe antileukemia drug, SAL Safe antileukemia drug, SAL

1987-05-14

1989-02-28

Rollins, John W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

514766, 514885, A61K 3119, A61K 31015

Patent

active

048086290

ABSTRACT:
A new pharmaceutical composition for treating nonlymphatic leukemia, such as granulocytic and monocytic leukemia comprising Harringtonine, Homoharringtonine, Anethole, Oleanolic acid and Ginsenoside and method of making the same.

REFERENCES:
patent: 4033818 (1977-07-01), Pourrat et al.
Chem. Abst. 83:15471s, 1987.
Merck Index, 9th ed., No. 6673, p. 887, 1976.

Affiliated with

Also associated with

Rating

Safe antileukemia drug, SAL does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Safe antileukemia drug, SAL, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Safe antileukemia drug, SAL will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1367592